the adoptive transfer of lymphokine-activated killer ( lak ) cells combined with low dose interleukin 2 ( il-2 ) mediates the regression of established pulmonary metastases in mice and has efficacy in the treatment of human cancer .
C0021756
interleukin 2
C0086418
human